Everyone jumped on the story of GRAIL, the exciting new spinout of sequencing giant Illumina Inc. Due to our weekly publishing cycle, I took more time to consider what other reporters hadn’t: the concept is exciting, but can they do it? What challenges will they face?
Lede: “Illumina Inc., a major force in San Diego’s genomics industry, launched a spinout last month loaded with both cash and cachet. But experts say its destined for challenges on its quest for oncology’s “holy grail.””
READ THE FULL STORY AT SAN DIEGO BUSINESS JOURNAL.